Categories
Health

Detroit expands Covid vaccine eligibility to auto staff

Chrysler Jefferson North Assembly Plant in Detroit, Michigan

Bill Pugliano | Getty Images

DETROIT – production workers in the city, such as B. Auto workers, can now receive the Covid-19 vaccine without restrictions such as age or proof of pre-existing conditions.

The expanded manufacturing worker eligibility in Detroit represents a significant expansion of the eligibility of auto workers to vaccinate after municipalities such as Boone County, Illinois adopted similar measures. It should help to ensure the safety of employees and to put the car systems into operation.

The United Auto Workers Union estimates that at least 10,000 of its members work in Detroit. A total number of the manufacturing workers living in the city were not immediately available.

Detroit’s rollout of the two-dose vaccines Moderna and Pfizer will be carried out in a conference center and clinics for key manufacturing operations, starting with two SUV plants for Stellantis (formerly Fiat Chrysler). Production workers who live or work in the city are eligible, Detroit Mayor Mike Duggan announced Tuesday.

“The auto companies and the UAW have done a great job so far, but nothing is as good as a vaccination,” Duggan said during a press conference at which UAW Vice President Cindy Estrada received a vaccination.

Detroit automakers put extensive safety measures and social distancing guidelines in place during a two-month shutdown of their plants last year to help reduce the spread of Covid-19. Security measures implemented included plastic barriers, masks and other things like temperature controls and logs when entering and exiting the facilities.

“Manufacturing workers, whether they are unions or not, have really been there during this whole pandemic and it has not been easy,” Estrada said. “We have had disease in our plans and deaths, so this is incredibly important.”

According to union spokesman Brian Rothenberg, fewer than 30 of the approximately 400,000 members of the UAW have died of Covid-19. He said the union was “working with the White House, governors and all of our partners on vaccine distribution plans.”

Stellantis employees in Boone County, Illinois were among the first auto workers to receive Covid-19 vaccinations. The company looks forward to “working with other health departments to provide vaccines to the rest of Stellantis employees according to local sales plans.”

“Today’s announcement is an important step in protecting our employees and our communities so that we can return to the life we ​​all want to live,” Stellantis said in a statement.

The Stellantis facility in Detroit, including a new facility that is not yet fully operational, is one of the largest manufacturing operations in the city. The company expects to have 8,000 people vaccinated initially.

General Motors also has a large plant in the city, but that plant will temporarily not produce vehicles until later this year due to construction.

Detroit has administered 90,170 doses (70.7% of the doses received) and scheduled more than 52,800 appointments, according to its website.

UAW Vice President Cindy Estrada will receive a Covid-19 shot during a press conference with Detroit Mayor Mike Duggan on March 2, 2021.

Screenshot

Categories
World News

Covid-19: Reside Updates on Brazil Variant, Instances and Vaccine

Here’s what you need to know:

Credit…Raphael Alves/EPA, via Shutterstock

In just a matter of weeks, two variants of the coronavirus have become so familiar that you can hear their inscrutable alphanumeric names regularly uttered on television news.

B.1.1.7, first identified in Britain, has demonstrated the power to spread far and fast. In South Africa, a mutant called B.1.351 can dodge antibodies, blunting the effectiveness of some vaccines.

Scientists have also had their eye on a third concerning variant, which arose in Brazil, called P.1. Research has been slower on P.1 since its discovery in late December, leaving scientists unsure how much to worry.

“I’ve been holding my breath,” said Bronwyn MacInnis, an epidemiologist at the Broad Institute.

Now, three studies offer a sobering history of P.1’s meteoric rise in the Amazonian city of Manaus. It most likely arose there in November and then fueled a surge in coronavirus cases. It came to dominate the city partly because of an increased contagiousness, the research found.

But it also gained the ability to infect some people who had immunity from previous bouts of Covid-19. And laboratory experiments suggest that P.1 could weaken the protective effect of a Chinese vaccine now in use in Brazil.

The studies have yet to be published in scientific journals. Their authors caution that findings on cells in laboratories do not always translate to the real world and that they’ve only begun to understand P.1’s behavior.

“The findings apply to Manaus, but I don’t know if they apply to other places,” said Nuno Faria, a virologist at Imperial College London who helped lead much of the new research.

But even with the mysteries that remain around P.1, experts say that it is a variant to take seriously. “It’s right to be worried about P.1, and this data gives us the reason why,” said William Hanage, an epidemiologist at the Harvard T.H. Chan School of Public Health.

P.1 is now spreading across the rest of Brazil and has been found in 24 other countries. In the United States, the Centers for Disease Control and Prevention has recorded six cases in five states: Alaska, Florida, Maryland, Minnesota and Oklahoma.

To reduce the risks of P.1 outbreaks and reinfections, Dr. Faria said it was important to double down on every measure we have to slow the spread of the coronavirus. Masks and social distancing can work against P.1. And vaccination can help drive down its transmission and protect those who do get infected from severe disease.

“The ultimate message is that you need to step up all the vaccination efforts as soon as possible,” he said. “You need to be one step ahead of the virus.”

United States › United StatesOn March 1 14-day change
New cases 56,672 –21%
New deaths 1,425 –17%
World › WorldOn March 1 14-day change
New cases 293,587 +2%
New deaths 6,610 –21%

U.S. vaccinations ›

Where states are reporting vaccines given

Alyssa Jost, 19, received her second dose of the Moderna vaccine at Cobre Valley Regional Medical Center in Gila County, Ariz.Credit…Juan Arredondo for The New York Times

In most parts of the United States, getting a coronavirus vaccine can feel like trying to win the lottery. People scour the internet for appointments under complex eligibility standards that vary from state to state, and even county to county.

In Indiana and Kentucky, anyone over 60 can get vaccinated, but you have to be 65 or 70 almost everywhere else. About 18 states are offering shots to grocery workers, and 32 are vaccinating teachers.

Then there is Gila County, Ariz., where any resident over 18 can walk into a clinic without an appointment and get a vaccine.

“The whole process is incredibly easy,” said Frank Struck, 24, an electrician and maintenance worker who got inoculated at a hospital in Globe, a town in the county, about 90 miles east of Phoenix. “No bureaucracy, no crazy lines — you just go in, get the shot and come out with peace of mind.”

Gila County started off with a set of qualifying standards as well. But it has been so successful at vaccinating its residents that it is now one of the first places in the United States to open eligibility to the general population.

During a pandemic that has claimed the lives of at least 209 county residents, many people in the county of 54,000 people have welcomed the broader availability of the vaccines, a boon that follows a harrowing surge in hospitalizations around the start of the year. The expanded vaccination campaign has coincided over the past two weeks with a 52 percent plunge in new cases.

Health officials and elected leaders warn that big challenges persist in Gila County, in part because, in a county where anybody can get the vaccine, not everybody wants it.

About 28 percent of county residents have received at least one dose so far, compared with the nationwide level of 14 percent, according to local health officials. Rhonda Mason, the chief nursing officer at the hospital in Globe, said the challenge ahead was to overcome misinformation and skepticism.

A hot dog vendor in Los Angeles reopened on Monday after being closed for two months. The restaurant has been in business since 1939.Credit…Frederic J. Brown/Agence France-Presse — Getty Images

Tens of thousands of students walked into classrooms in Chicago public schools on Monday for the first time in nearly a year. Restaurants in Massachusetts were allowed to operate without capacity limits, and venues like roller skating rinks and movie theaters in most of the state opened with fewer restrictions. And South Carolina erased its limits on large gatherings.

Across the country, the first day of March brought a wave of reopenings and liftings of pandemic restrictions, signs that more Americans were tentatively emerging from months of isolation, even if not everyone agrees that the time is ripe.

There are plenty of reasons for optimism: Vaccinations have increased significantly in recent weeks, and daily reports of new coronavirus cases have fallen across the United States from their January peaks.

In Kentucky, all but a handful of school districts are now offering in-person classes, while the state races to vaccinate teachers as quickly as possible. Gov. Andy Beshear told reporters last week that the state’s falling infection statistics showed that immunizations were beginning to make an impact.

“It means vaccinations work,” he said. “We’re already seeing it. We’re seeing it in these numbers. It’s a really positive sign.”

Dr. Anthony S. Fauci, President Biden’s chief medical adviser for Covid-19, said at a news briefing on Monday that for small groups of people who have all been fully vaccinated, there was a low risk in gathering together at home. Activities beyond that, he said, would depend on data, modeling and “good clinical common sense,” adding that the Centers for Disease Control and Prevention would soon have guidance for what vaccinated people could safely do.

The positive signs come with caveats. Though the national statistics have improved drastically since January, they have plateaued in the last week or so, and the United States is still reporting more than 65,000 new cases a day on average — comparable to the peak of last summer’s surge, according to a New York Times database. The country is still averaging about 2,000 deaths per day, though deaths are a lagging indicator because it can take weeks for patients to die.

More contagious variants of the virus are circulating in the country, with the potential to push case counts upward again. Testing has fallen 30 percent in recent weeks, leaving experts worried about how quickly new outbreaks will be known. And millions of Americans are still waiting to be vaccinated.

Given all that, some experts worry that the reopenings are coming a bit too soon.

“We’re, hopefully, in between what I hope will be the last big wave, and the beginning of the period where I hope Covid will become very uncommon,” said Robert Horsburgh, an epidemiologist at the Boston University School of Public Health. “But we don’t know that. I’ve been advocating for us to just hang tight for four to six more weeks.”

The director of the C.D.C., Dr. Rochelle Walensky, said at the briefing on Monday that she was “really worried” about the rollbacks of restrictions in some states. She cautioned that with the decline in cases “stalling” and with variants spreading, “we stand to completely lose the hard-earned ground we have gained.”

And the plateauing case levels “must be taken extremely seriously,” Dr. Walensky warned at a briefing last week. She added: “I know people are tired; they want to get back to life, to normal. But we’re not there yet.”

After some counties in Washington State allowed movie theaters to reopen, Nick Butcher, 36, made up for lost time by attending screenings of the “Lord of the Rings” trilogy for three straight nights. He bought some M&Ms at the concession stand, sat distanced from others in the audience, and said he felt as though things were almost back to normal.

“I’m actually getting optimistic, over all,” said Mr. Butcher, a software engineer at Microsoft who recently recovered from a case of Covid-19, as did several relatives. “This week is one of the first times I’ve gone into my office almost since the pandemic started.”

Thermal scanners check every visitor to the Student Union Building at the University of Idaho in Moscow, Idaho. So far, only 10 people have been turned away and instructed to get a coronavirus test.Credit…Rajah Bose for The New York Times

Before the University of Idaho welcomed students back to campus last fall, it spent $90,000 installing temperature-scanning stations, which look like airport metal detectors, in front of its dining and athletic facilities in Moscow, Idaho. When the system detects a student walking through with an unusually high temperature, the student is asked to leave and get tested for the coronavirus.

But so far, the fever scanners, which register skin temperature, have flagged fewer than 10 people out of the 9,000 students living on or near campus. Even then, university administrators could not say whether the technology had been effective because they have not tracked students detected with fevers to see if they went on to get tested.

The University of Idaho is one of hundreds of colleges and universities that adopted fever scanners, symptom checkers, wearable heart-rate monitors and other screening technologies this school year. Such tools often cost less than a more validated health intervention: frequent virus testing of all students. They also help colleges showcase their pandemic safety efforts.

But the struggle at many colleges to keep the virus at bay has raised questions about the usefulness of the technologies. According to a New York Times database, there have been more than 530,000 virus cases on campuses since the start of the pandemic.

One problem is that temperature scanners and symptom-checking apps cannot catch the estimated 40 percent of people with the coronavirus who do not have symptoms but are still infectious. Temperature scanners can also be wildly inaccurate. The Centers for Disease Control and Prevention has cautioned that such symptom-based screening has only “limited effectiveness.”

The schools have a hard time saying whether — or how well — the devices have worked. Many universities and colleges are not rigorously studying effectiveness.

More than 100 schools are using a free symptom-checking app, CampusClear, that can permit students to enter campus buildings. Others are asking students to wear symptom-monitoring devices that can continuously track vital signs like skin temperature.

Administrators at Idaho and other universities said their schools were using the technology, along with policies like social distancing, as part of larger campus efforts to hinder the virus. Some said it was important for their schools to deploy the screening tools even if they were only moderately useful.

At the very least, they said, using services like daily symptom-checking apps may reassure students and remind them to be vigilant about other measures, like mask wearing.

Marcela Valladolid, left, the California chef and media personality, began teaching cooking classes with her sister, Carina Luz, on Zoom. The experience led to a cookbook.Credit…Karla Ortiz

The books that Americans cooked from during 2020 will stand as cultural artifacts of the year when a virus forced an entire nation into the kitchen.

The pandemic has been good to cookbooks. Overall sales jumped 17 percent from 2019, according to figures from NPD BookScan, which tracks about 85 percent of book sales in the United States.

Some of the smash hits were predictable. The world domination of Joanna Gaines, the queen of shiplap, continued. The second volume of her hugely popular “Magnolia Table” cookbook franchise sailed to the top of the New York Times list of the best-selling cookbooks in 2020. Ina Garten, the cooking doyenne from the Hamptons, landed the second spot with “Modern Comfort Food,” followed by “The Happy in a Hurry Cookbook,” by the “Fox & Friends” host Steve Doocy and his wife, Kathy.

But the stir-crazy year upended the way people cook and think about food in fundamental ways.

One of the year’s 10 best-selling cookbooks on a list complied by BookScan offered 600 air-fryer recipes, owing as much to the appliance’s ability to crisp up takeout French fries as it does to its popularity with the Trader Joe’s set, who made it through the year by heating up vegetarian egg rolls and mac-and-cheese bites. It sold more than 135,000 copies.

By contrast, 30,000 copies may not sound like much, but those sales figures were big for “Cool Beans” by Joe Yonan, a treatise whose own editor predicted “would never set the world on fire.”

Everyday cooks went in search of new cuisines and projects to break up the routine. Practiced cooks who might have spent a Saturday afternoon before the pandemic hand-rolling pasta sought recipes that would help keep weeknight cooking from becoming a grind.

Plenty of people simply needed help getting any meal on the table, which drove the popularity of general cookbooks. That category was the largest of cookbooks bought in 2020, according to BookScan. Sales showed a 127 percent increase over 2019.

And underscoring the great American food dichotomy, both dessert and diet books sold well.

Students were back at Hawthorne Scholastic Academy in Chicago on Monday as they returned to in-person learning.Credit…Scott Olson/Getty Images

Scientists and doctors who study infectious disease in children largely agreed, in a recent New York Times survey about school openings, that elementary school students should be able to attend in-person school now. With safety measures like masking and opening windows, the benefits outweigh the risks, the majority of the 175 respondents said.

They gave The Times comments on key topics, including the risks to children of being out of school; the risks to teachers of being in school; whether vaccines are necessary before opening schools; how to achieve distance in crowded classrooms; what kind of ventilation is needed; and whether their own children’s school districts got it right.

In addition to their daily work on Covid-19, most of the experts had school-aged children themselves, half of whom were attending in-person school.

They also discussed whether the new variants could change even the best-laid school opening plans. “There will be a lot of unknowns with novel variants,” said Pia MacDonald, an infectious disease epidemiologist at RTI International, a research group. “We need to plan to expect them and to develop strategies to manage school with these new threats.”

Most of the respondents work in academic research, and about a quarter work as health care providers. We asked them what their expertise taught them that they felt others needed to understand.

Over all, they said that data suggests that with precautions, particularly masks, the risk of in-school transmission is low for both children and adults.

People lined up for coronavirus vaccines at the drive-up site at the Walmart store in Lauderdale Lakes, Fla., last week.Credit…Joe Cavaretta/South Florida Sun-Sentinel, via Associated Press

New York City added workers in the food service and hotel industries to the list of people eligible for coronavirus vaccination on Monday, the same day the governors of Florida and Ohio announced expansions for eligibility in their states.

The expansions come as the supply of vaccines being distributed nationally is ramping up, and after a third vaccine, a single-shot dose from Johnson & Johnson, was authorized for emergency use by the Food and Drug Administration over the weekend. The pace of U.S. vaccinations is again accelerating, up to about 1.82 million doses per day on average, according to a New York Times database, above last month’s peak before snowstorms disrupted distribution.

In New York City, people who work in regional food banks, food pantries and “permitted home-delivered” meal programs became eligible on Monday to receive a vaccine. Hotel workers who have direct contact with guests also became eligible.

The governor of Florida, Ron DeSantis, said on Monday that people 50 and older who work in K-12 schools, law enforcement or firefighting would become eligible on Wednesday. Florida was one of the first states that decided to vaccinate anyone 65 and older, even before most essential workers, which led to long lines and confusion.

Gov. Mike DeWine of Ohio said on Monday that the state would receive more than 448,000 doses this week, including more than 96,000 doses of the Johnson & Johnson vaccine. He said that “in response to this significant increase in the amount of vaccine coming into Ohio,” a new group of people would be eligible on Thursday to get a shot.

That group includes people with Type 1 diabetes, pregnant women and certain workers in child care and funeral services, as well as law enforcement and corrections officers.

To stay ahead of more contagious and possibly more deadly virus variants, states have been racing to ramp up vaccinations and expand eligibility. But they have often done so before the supply could increase quickly enough, creating shortages and making it harder for people to get vaccination appointments.

Frontier Airlines is facing accusations of anti-Semitism for its treatment of the passengers, who are Hasidic Jews.Credit…Tony Dejak/Associated Press

A Frontier Airlines flight from Miami to La Guardia Airport in New York was canceled on Sunday night after a large group of passengers, including several adults, refused to wear masks, the airline said.

By Monday morning, the airline was facing accusations of anti-Semitism for its treatment of the passengers, who are Hasidic Jews, as well as demands for an investigation from the Anti-Defamation League of New York and other groups. Frontier steadfastly held to its position that the passengers had refused to comply with federal rules requiring them to wear masks.

Several phone videos that have surfaced do not show the confrontation that took place between the passengers and the Frontier crew members, only the aftermath. The video footage from inside the aircraft appeared to show members of the group wearing masks. Some passengers said that the episode escalated because just one member of the group, a 15-month-old child, was not wearing one.

Videos of the passengers exiting the plane amid chaos, captured by other people on the flight, were posted on Twitter by the Orthodox Jewish Public Affairs Council. In one video, a passenger says, “This is an anti-Semitic act.”

Another video showed a couple holding a maskless baby in a car seat, as children could be heard crying and a woman explained that the young children in their group, sitting in the back of the plane, had taken off their masks to eat.

A Frontier Airlines spokeswoman said in a statement that “a large group of passengers repeatedly refused to comply with the U.S. government’s federal mask mandate.”

Categories
Health

Russia’s Sputnik vaccine is luring Jap Europe, worrying the EU

A medical worker holds a syringe with the Gam-COVID-Vac (Sputnik V) Covid-19 vaccine in his hand.

Alexander Reka | TASS | Getty Images

While the European Union struggles to push coronavirus vaccine rollout in the block of 27, Russia’s Covid shot is proving enticing to its friends in Eastern Europe, creating yet another potential rift in the region.

The Czech Republic, Austria, Hungary and Slovakia have all expressed an interest in the procurement and use of the Russian vaccine “Sputnik V”, which could undermine an EU-wide approach to the approval and administration of coronavirus vaccines.

Czech Prime Minister Andrej Babis said on Sunday that his country could use the Sputnik V vaccine without the approval of the EU Medicines Agency, the European Medicines Agency.

It comes after Russian President Vladimir Putin and Austrian Chancellor Sebastian Kurz received a call last Friday in which they discussed “possible deliveries of the Russian Sputnik-V vaccine to Austria and its possible joint production,” the Kremlin said and found that Austria had initiated the call. Austria has so far stated that it would not bypass the EMA when approving the vaccine.

Hungary, a country within the EU that has close ties to Brussels and whose leader Viktor Orban is considered a close ally of Putin, has shown no such hesitation. It was the first European country to bypass the EMA to approve and purchase the Sputnik V vaccine in January.

According to the Moscow Times, the country expects 2 million doses of the Sputnik V vaccine to be administered over the next three months. Hungary also approved China’s Sinopharm vaccine last month, which again goes against the grain when it comes to EU vaccine approval.

On Monday, Slovakia became the second European country to announce that it had purchased the Sputnik V vaccine, which secured 2 million doses of the shot. However, the Slovak Minister of Health said it will not be given immediately as it still needs the green light from the country’s national drug regulator.

A Slovak Army plane carrying doses of the Sputnik V vaccine against the coronavirus (Covid-19) stands on the tarmac when it arrives from Moscow at Kosice International Airport, Slovakia, on March 1, 2021.

PETER LAZAR | AFP | Getty Images

What’s happening?

The linchpin for the Russian vaccine is widespread frustration with the slow adoption of EU vaccines. The bloc’s decision to jointly buy vaccines has hampered it, and its orders came later than in other countries, including the UK and US

Manufacturing problems and bureaucracy – and hesitation in some countries about vaccines – were also stumbling blocks to adoption.

Nonetheless, the move by some Eastern European countries to unilaterally support Russia’s vaccine will exacerbate problems in Brussels as it undermines the EU’s desire for a unified approach and a sense of equity in the distribution of vaccines.

There were also concerns specifically about Sputnik V, although subsequent data have confirmed the vaccine’s effectiveness and credibility.

The vaccine was approved by the Russian health authority in August last year, ahead of the completion of clinical trials, causing skepticism among experts that it may not meet strict safety and efficacy standards. Some experts argued that the Kremlin is keen to win the race to develop a Covid vaccine.

However, an interim analysis of the Phase 3 clinical trials with 20 participants published in The Lancet in early February found the vaccine to be 91.6% effective against symptomatic Covid-19 infections.

In a companion article in the Lancet, Ian Jones, Professor of Virology at the University of Reading, England noted that “the development of the Sputnik V vaccine has been criticized for undue urgency. However, the result reported here is clear and scientific. The principle of vaccination is demonstrated which means another vaccine can now join the fight to reduce the incidence of Covid-19. “

However, the Gamaleya National Center for Epidemiology and Microbiology in Moscow, which developed the vaccine, has not yet submitted an application to the EMA for marketing authorization for the vaccine, the EU Medicines Agency said in early February.

A woman receives the second component of the Gam-COVID-Vac (Sputnik V) COVID-19 vaccine.

Valentin Sprinchak | TASS | Getty Images

RDIF, Russia’s sovereign wealth fund that backed the development of Sputnik V, announced to CNBC on Monday that it had requested the EU Drugs Agency for an ongoing vaccine review in mid-February. However, the EMA has not confirmed this and CNBC has asked the EMA for a comment.

Political theater

The European Commission already warned Hungary, albeit indirectly, against the use of the Russian vaccine before the EMA approved it. As early as November, a spokesman for the Commission told Reuters: “The question is whether a Member State would like to give its citizens a vaccine that has not been tested by the EMA.” Public confidence in vaccination could be damaged.

“This is where the approval process and confidence in vaccines meet. When our citizens start questioning the safety of a vaccine, it will be much more difficult to get a sufficient proportion of vaccines if it has not undergone rigorous scientific evaluation. to demonstrate its safety and effectiveness to the population, “said the spokesman, reported Reuters.

However, the decision of Hungary to proceed alone with the vaccine against Sputnik V does not surprise the EU observers. The country’s right-wing leader, Viktor Orban – a “strong man” like Russia’s Putin – has had several disputes with the EU executive in recent years, particularly over signs of the government’s increasing authoritarianism. The erosion of the independence of the judiciary and freedom of the press in Hungary is of particular concern to the EU. However, the Hungarian government rejects such criticism.

Gustav Gressel, Senior Policy Fellow at the European Council on Foreign Relations, told CNBC on Monday that Hungary’s actions were “part of Orban’s campaign to promote a” decadent, declining EU “and the future of Hungary in the east with Russia and China.” said it had been going on for some time.

Daragh McDowell, head of Europe and chief analyst for Russia at Verisk Maplecroft, described the geopolitics surrounding Sputnik V and the EU as “political theater more than anything”.

“For Hungary and Austria there is an element of foreign policy signaling here, as both Kurz and Orban generally had a closer relationship with Putin than their European counterparts. In the case of the Czech Republic, the impetus seems to have been more towards the government “Take action” in the face of a rapid surge in the number of cases in February, “he said.

There are also doubts as to whether Russia will be able to mass-produce and ship its Sputnik V vaccine to Europe.

“While the Sputnik vaccine appears to be an effective vaccine in principle, Russia is having great difficulty getting mass production right … enough Sputnik vaccine is still not being made,” Gressel said. McDowell noted that “the question is whether Sputnik V can make a noticeable difference, given regulatory issues and existing logistical issues, and whether the vaccine can be made in sufficient numbers either by Russian manufacturers or under license.”

Categories
Politics

Trump and his spouse obtained coronavirus vaccine earlier than leaving the White Home.

Former President Donald J. Trump and his wife Melania were tacitly given coronavirus vaccinations in January before leaving the White House, an adviser said Monday.

The news came a day after Mr Trump appeared at the CPAC political conference in Orlando, Florida, where he first encouraged people to get vaccinated.

“Everyone should go to get your shot,” said Mr. Trump during the speech. When The Times asked an adviser to the former president if he had received his, the answer was that he had one privately a month earlier.

Mr Trump’s secret approach came when some of his supporters expressed opposition to the vaccine and other officials tried to set an example by making the shot public.

President Biden, Vice President Kamala Harris, and former Vice President Mike Pence received vaccination shots on television cameras.

Mr. Trump’s concern about the vaccine has generally been whether as president he will get credit for his development. He never publicly encouraged people to take it while in office; The first vaccines were approved shortly after election day.

The adviser did not say whether Mr Trump had received both his first and second vaccinations in January or whether the second came at a different time.

Mr and Mrs Trump were both infected with the coronavirus in the fall, and the former president was hospitalized with a serious case.

Categories
Health

A Covid Vaccine Facet Impact, Enlarged Lymph Nodes, Can Be Mistaken for Most cancers

Coronavirus vaccinations can cause enlarged lymph nodes in the armpit or near the collarbone, which may be mistaken for a sign of cancer.

As vaccines roll out across the country, doctors are seeing more and more of these swollen lumps in recently vaccinated people, and medical journals have started publishing reports aimed at reducing anxiety and helping patients avoid unnecessary testing for a harmless condition that will go away a couple of weeks.

The swelling is a normal immune system response to the vaccine and occurs on the same side as the arm the shot was fired on. It can also occur after other vaccinations, including those for the flu and human papillomavirus (HPV). Patients may or may not notice it. However, the enlarged lymph nodes appear as white spots on mammograms and breast scans and are similar to pictures that may indicate the spread of cancer through a tumor in the breast or elsewhere in the body.

“I make special efforts to inform all patients who are being monitored after successful previous cancer treatment,” said Dr. Constance D. Lehman, author of two magazine articles on the problem and director of breast imaging at Massachusetts General Hospital. “I can’t imagine the fear of getting the scan and hearing. ‘We found a lump that is big. We don’t believe it is cancer, but we can’t tell, or worse, we believe it could be cancer. “

The armpit swelling was a recognized side effect in the large studies of the Moderna and Pfizer-BioNTech vaccines. In Moderna’s study, 11.6 percent of patients reported swollen lymph nodes after the first dose and 16 percent after the second dose. Pfizer-BioNTech appeared to have a lower incidence, with 0.3 percent of patients reporting it. However, these numbers only reflect what patients and their doctors have noticed, and radiologists say the real rate is likely higher and that imaging such as mammograms, MRIs, or CT scans are likely to have many more cases.

The condition was not listed among the reported side effects in a Food and Drug Administration information document about the Johnson & Johnson Covid vaccine. On Saturday, the agency approved the company’s emergency vaccine.

Dr. Lehman said it was important for imaging centers to ask patients if they received Covid vaccinations and to record the date of the shot and the arm it was placed in.

Your clinic includes this notice in a letter to patients whose screening reveals swelling but no other abnormalities: “The lymph nodes in your armpit area that we see on your mammogram are on the page where you got your last Covid-19 vaccine got bigger. Enlarged lymph nodes are common after the Covid-19 vaccine and are your body’s normal response to the vaccine. However, if you feel a lump in your armpit that lasts more than six weeks after your vaccination, you should tell your doctor. “

One way to avoid the problem is to postpone routine mammograms and other imaging tests for at least six weeks after the last dose of vaccine. This comes from a panel of experts article in Radiology magazine published on Wednesday.

Updated

March 1, 2021, 3:41 p.m. ET

A professional group, the Society of Breast Imaging, offers similar advice: “If possible and if care is not unduly delayed, you should schedule screening exams before the first dose of Covid-19 vaccine or 4-6 weeks after the second dose.” a Covid-19 vaccination. “

However, the panel of experts also warned that non-routine imaging, which is needed to treat a disease or other symptoms that could suggest cancer, should not be delayed. Immunization should also not take place.

People with cancer are generally recommended to get vaccinated against the coronavirus, especially because they are at a higher risk of dying from Covid than the general population. However, some cancer treatments can affect the body’s ability to fully respond to the vaccine, and the American Cancer Society advises patients to consult with their oncologists about vaccinations.

Recently vaccinated people who have cancer and develop enlarged lymph nodes may need additional tests, including a biopsy of the nodes, said Dr. Lehman.

She described a patient with a newly diagnosed breast tumor who had swollen lymph nodes on the same side and who had recently received a Covid shot in the arm on that side.

A biopsy was performed, an important step to determine if there were any malignant cells in the nodes, which would then help determine a course of treatment. It was negative for cancer. The vaccine most likely caused the swelling.

In another case, a woman who previously had cancer of the right breast had a routine mammogram that showed an enlarged lymph node in her left armpit and no other abnormality. She recently had a Covid vaccination on her left arm. Doctors found that no further testing would be needed if the swollen lumps did not last more than six weeks.

A man with a history of bone cancer did a chest CT scan as part of a follow-up exam found swollen lymph nodes in one armpit – on the side where he had recently received a Covid shot. Nothing else was wrong and no further testing was required. The same decision was made for similar findings in a recently vaccinated man who had a chest CT scan to screen for lung cancer and in a woman with a history of melanoma.

For patients undergoing cancer treatment in one breast, the Covid shot should be given in the arm on the other side, said Dr. Lehman. The vaccine can also be injected into the thigh to avoid problems with lymph node swelling.

“This could really affect a lot of people if we don’t get vaccination status straight away in imaging centers,” said Dr. Lehman. “I also want cancer patients to know that they can get the vaccine on the opposite side or even on the leg to avoid confusion.”

Categories
Health

Why I Overcame My Vaccine Hesitancy

At the mass vaccination site I went to in Brooklyn, everyone I met was cheerful, patient, and reassuring, even the young woman who checked me in and couldn’t find me on her 3pm schedule. “Don’t worry,” she said soothingly, “you will get the vaccine.”

At the next window, a young man from Nigeria checked my ID and Medicare card and found out what had happened. Turns out I accidentally booked an appointment at 3am and didn’t know the website was open 24/7. Another “don’t worry,” and I went to see a young Florida technician who painlessly injected the Moderna vaccine into my left arm.

I then sat in a holding tent for 15 minutes to make sure I wouldn’t have any serious reactions. The next day I received a text: “Hello Jane, it’s time for your daily v-safe check-in” and a link to a CDC site that asked: How are you today? (Good, fair, bad); Did you have a fever today or did you have a fever? (Yes No); followed by symptom testing, first at the injection site for pain, redness, swelling or itching and then generally for chills, headache, joint pain, muscle or body aches, tiredness or exhaustion, nausea, vomiting, diarrhea, abdominal pain and rash or any other symptoms that I wanted to report.

Finally, I was asked some general health effects related to my ability to work and carry out my normal daily activities and whether I needed to see a doctor. I received the same text at the same time every day for more than a week and also received a link when I wanted to submit a report to the Vaccine Adverse Event Reporting System.

The second dose, given 34 days later, went even more smoothly. By then I had spoken to dozens of other people of different ages who had both taken recordings. Only two reported bad reactions – fever, nausea, extreme fatigue – that lasted a day or two. I was prepared for the worst, but it never happened. My arm, shoulder, and neck hurt the first night, but most of the pain was gone by the next morning. Although my son was on call if I couldn’t walk my dog, his help was not needed. I was even able to swim that afternoon.

Categories
Health

Covid vaccine for elementary college kids doubtless coming in 2022

Saundra Murphys third grade students participate in silent reading at the start of class on the first day of class at Weaverville Elementary School on Monday, August 17, 2020 in Weaverville, CA.

Kent Nishimura | Los Angeles Times | Getty Images

Primary school children are likely to get Covid-19 vaccinations early next year, said Dr. Anthony Fauci on NBC’s “Meet the Press” on Sunday advance.

Fauci, the government’s leading epidemiologist, said vaccine safety studies for younger children are ongoing.

“If you realistically project when we will be able to get enough data to say that elementary school children can be vaccinated, I would think that this would be the end of the year at the earliest and very likely the first quarter of 2022 “said Fauci.

Federal regulators have approved three Covid-19 vaccines to fight the pandemic. Two vaccines made by Johnson & Johnson and Moderna are approved for adults aged 18 and over.

The Pfizer BioNTech vaccine can be given to people aged 16 and over, although currently eligibility for young people is strictly limited to those who meet certain criteria, e.g. B. the underlying diseases.

Vaccinating children could help states and communities open schools and safely return to teaching in person. Fewer children than adults may have Covid-19, according to the Centers for Disease Control and Prevention, but they can still contract the virus, become seriously ill, and pass it on to others.

Fauci said students can likely get vaccines early in the fall school year.

“I’m not sure if it’s exactly the first day the school opens, but it’s pretty close,” he said.

According to CDC data, more than 72 million vaccine doses have been administered in the US to date. About one in five adults has received at least one dose and about one in ten adults has received two.

Johnson & Johnson’s single-dose vaccine was approved for emergency use by the Food and Drug Administration on Saturday and is designed to expedite the campaign to vaccinate every American. The federal government plans to hand out four million cans next week.

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest during the next president’s term.

Categories
Business

CDC panel recommends use of J&J’s single-shot Covid vaccine

Illustration of the Johnson & Johnson coronavirus vaccine

Given Ruvic | Reuters

An advisory panel to the Centers for Disease Control and Prevention unanimously voted on Sunday to recommend the use of Johnson & Johnson’s one-off Covid-19 vaccine for those ages 18 and older as the federal government prepares to serve millions of doses this week to send .

As soon as CDC director Dr. Rochelle Walensky accepts the recommendation of the Advisory Committee on Immunization Practices, the federal government can begin shipping doses to locations across the country. The ACIP met in an emergency meeting to review the vaccine dates, which took place on Saturday became the third shot to receive emergency clearance from the Food and Drug Administration.

Walensky said Friday that she “would be ready to review the ACIP recommendation” and “be ready to sign”.

“We are very close to having another vaccine in our tool boxes, the Johnson & Johnson Covid-19 Vaccine. Like many of you, I am pleased to hear that another safe and effective vaccine option could be coming as soon as next week “She said Friday. “An additional safe and effective vaccine will help protect more people, faster.”

Dr. Richard Nettles, vice president of medical affairs at J&J, told lawmakers Tuesday that the company was ready to ship nearly 4 million doses once it receives emergency approval. He added that the company expects to have 20 million cans ready by the end of March.

The introduction of the J&J shot could be a boon to the U.S. vaccine supply. While the new vaccine showed signs of being less effective at preventing Covid-19 in clinical trials when compared to Pfizer-BioNTech and Moderna vaccines, the J&J shot was 100% effective at preventing deaths and hospitalizations, caused by Covid-19 in clinical trials.

The level of protection of the J&J vaccine against Covid-19 in studies varied regionally, according to FDA documents released on Wednesday. About a month after inoculation, the shot showed 72% effectiveness in the US, 61% in Latin America and 64% in South Africa, where variant B.1.351 is spreading rapidly.

In particular, the FDA review found the vaccine was significantly less effective in people aged 60 and over who also had comorbidities like diabetes or heart disease. However, the agency found that the data was too sparse for any conclusions to be drawn.

In contrast, in clinical studies, Pfizer’s vaccine has been found to be 95% effective against Covid-19, while Moderna’s vaccine is around 94% effective. Infectious disease experts pointed out that J & J’s numbers cannot be used as a head-to-head comparison with the other two vaccines because it is a single dose and the company’s study was conducted when more infections, as well as new, more contagious variants occurred.

However, federal health officials have indicated that the one-off J&J regime offers unique logistical benefits that could make it ideal for hard-to-reach populations.

J & J’s vaccine “makes it easier to use in many contexts,” said Dr. Nancy Messonnier, director of the National Center for Immunization and Respiratory Diseases of the CDC, told the Journal of the American Medical Association during a question and answer session Friday. “I suspect that much of the national health consideration given to these vaccines is more about the ease of use of the J&J vaccine and how it might be better suited to some populations.”

J&J has announced that it will ship the vaccine, which contains five doses per vial, at 36 to 46 degrees Fahrenheit. In comparison, Pfizer’s vaccine typically has to be stored in ultra-cold freezers, which are between minus 112 and minus 76 degrees Fahrenheit. However, the FDA recently announced that it could be stored in pharmacies for up to two weeks at standard freezing temperatures. Moderna vaccine must be shipped at 13 to 5 degrees above zero Fahrenheit.

– CNBC’s Berkeley Lovelace contributed to this report.

Categories
Health

Right here is How Johnson & Johnson’s Vaccine Differs from Pfizer and Moderna’s

A third effective weapon was added to the American arsenal against the coronavirus on Saturday when the Food and Drug Administration granted emergency approval for a vaccine developed by Johnson & Johnson.

The company announced it would begin shipping millions of cans earlier this week and ship 100 million cans to the US by the end of June. Together with 600 million doses of the country’s first two approved vaccines, manufactured by Pfizer-BioNTech and Moderna, due to be dispensed over the next four months, that should be enough to cover every American adult who wants to be vaccinated.

The new vaccine is very different from the two already used in the US. Here’s how they compare.

The Johnson & Johnson vaccine is given in one shot, while the Pfizer BioNTech and Moderna vaccines are given in two shots several weeks apart.

The Johnson & Johnson vaccine uses a different method to prepare the body to fight Covid-19: a viral vector called Ad26. Viral vectors are common viruses that have been genetically modified so that they do not cause disease, but can still cause the immune system to build up its defenses. The vaccines Pfizer-BioNTech and Moderna use messenger RNA for this.

The Johnson & Johnson vaccine is found to be highly effective in preventing serious illness and death, as are Pfizer-BioNTech and Moderna vaccines. It’s also very effective in preventing milder diseases, albeit a little less than either of these. It appears to be good against the highly contagious variant B.1.351, which was first identified in South Africa and has caused problems at least one other vaccine candidate.

The Johnson & Johnson vaccine does not need to be stored at extremely low temperatures like the Pfizer BioNTech vaccine. It can be safely stored in a regular refrigerator for three months, much longer than the Moderna vaccine, which spoils after a month if left frozen.

The Johnson & Johnson vaccine appears to be less susceptible than the Pfizer-BioNTech and Moderna vaccines to causing the types of side effects that need to be monitored after injection, which may make it more suitable for drive-through vaccination site use. It has been reported that side effects tend to be more felt after second doses that the Johnson & Johnson vaccine doesn’t need.

Categories
Health

FDA approves J&J’s single-shot Covid vaccine for emergency use

The Food and Drug Administration has approved Johnson & Johnson’s Covid-19 vaccine for emergency use. This gives the US a third tool to fight the pandemic as highly contagious variants are gaining a foothold across the country.

With the FDA’s approval for the emergency on Saturday, the federal government’s plan begins to distribute nearly 4 million doses of J & J’s vaccine to states, pharmacies and community health centers across the country next week. Unlike Pfizer and Moderna vaccines, patients with the single dose of J&J do not need to take a second dose and can be stored at refrigerator temperature for months.

J & J’s vaccine “makes it easier to use in many contexts,” said Dr. Nancy Messonnier, director of the National Center for Immunization and Respiratory Diseases of the CDC, told the Journal of the American Medical Association during a question and answer session Friday. “I suspect that much of the national health consideration given to these vaccines is more about the ease of use of the J&J vaccine and how it might be better suited to some populations.”

Initially, doses would be limited, J&J said. The company expects to drop 20 million doses by the end of March, said Dr. Richard Nettles, vice president of medical affairs in the US, told the House legislature on Tuesday. J&J has signed a contract with the US government to supply 100 million doses of its vaccine by the end of June. US officials say they are working with the company to increase supply as soon as possible.

In the past few weeks, US health officials have urged Americans to get vaccinated as soon as possible. Officials are increasingly concerned about new, emerging variants of the virus, particularly strain B.1.351, which has been shown to decrease the effectiveness of vaccines both in market and in development. On Friday, the head of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, the declines in Covid-19 cases reported in the US since early January could flatten as the variants spread.

J&J submitted its Covid vaccine data to the FDA on February 4th. The vaccine’s level of protection varies from region to region, J&J said, with the shot showing an effectiveness of 66% overall, 72% in the US, 66% in Latin America and 57% in South Africa, where variant B.1.351 is spreading rapidly. However, FDA documents show that the vaccine was 64% effective in South Africa after about a month. The company said the vaccine prevented 100% of hospital stays and deaths.

The Pfizer vaccine was found to be 95% effective against Covid-19, while the Moderna vaccine was around 94% effective. Infectious disease experts pointed out that J & J’s numbers cannot be used as a head-to-head comparison with the other two vaccines because it is a single dose and the company’s study was conducted when more infections, as well as new, more contagious variants occurred.

The FDA has announced that it will approve a Covid-19 vaccine that is safe and at least 50% effective. In comparison, the flu vaccine generally reduces the risk of developing influenza by 40% to 60% compared to people who were not vaccinated, according to the CDC.

The FDA has approved J & J’s vaccine for people 18 years of age and older. This is not the same as a full approval which requires more data and which can typically take several months longer. J&J, like Pfizer and Moderna, has only submitted safety data for two months, but the agency typically takes six months for full approval. The FDA approved the emergency use of hydroxychloroquine to treat Covid-19 in March but revoked it in June after additional data showed it provided “no indication of benefit” in coronavirus patients.

The FDA was expected to approve J & J’s emergency vaccine.

The agency’s announcement comes after a key panel unanimously endorsed the emergency vaccine on Friday. The FDA’s Advisory Panel on Vaccines and Related Biological Products plays a key role in approving influenza and other vaccines in the United States and verifying that the vaccines are safe for public use. While the FDA does not have to follow the advisory board’s recommendation, it often does.

After the vote, Dr. Archana Chatterjee, an infectious disease expert at Chicago Medical School and voting committee member, said J & J’s vaccine will help “meet the needs of the moment” as states complain that there is insufficient supply Pfizer and Moderna gives vaccinations.

“We have to get this vaccine out now,” said Dr. Jay Portnoy, professor at UMKC School of Medicine and voting committee member, after the vote. He added, “We are in a hurry” as the variants pose a threat to the nation’s progress on the pandemic.

No specific safety concerns were identified with J & J’s vaccine. Headache, fatigue, and muscle aches were some of the most common side effects among people who received the vaccination, according to an FDA report released Wednesday. There have also been reports of nausea, fever and injection site pain, the report said.

Macaya Douoguih, director of clinical development and medical affairs for the vaccines division at J & J, Janssen, told the FDA panel on Friday that two people had severe allergic reactions shortly after receiving the vaccine. One of the people participated in an ongoing study in South Africa and developed anaphylaxis, a severe and life-threatening allergic reaction.

The company has announced that it will ship the vaccine, which contains five doses per vial, at 36 to 46 degrees Fahrenheit. In comparison, Pfizer’s vaccine must be stored in ultra-cold freezers that are between minus 112 and minus 76 degrees Fahrenheit. However, the FDA recently allowed the company to store its vaccine for two weeks at temperatures commonly found in pharmaceutical freezers. Moderna vaccine must be shipped at 13 to 5 degrees above zero Fahrenheit.

This is a developing story. Please try again.